These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 17298352)
21. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment? Epstein TE; Tankersley MS J Allergy Clin Immunol Pract; 2017; 5(5):1227-1233. PubMed ID: 28709818 [No Abstract] [Full Text] [Related]
22. [The mechanisms of allergen-specific immunotherapy more clear]. Rak S Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375 [No Abstract] [Full Text] [Related]
23. Regulatory control and standardization of allergenic extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):177-220. PubMed ID: 3196018 [No Abstract] [Full Text] [Related]
30. Treating allergy: where to from here? O'Hehir RE Intern Med J; 2009 Aug; 39(8):491-4. PubMed ID: 19732196 [No Abstract] [Full Text] [Related]
31. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280 [TBL] [Abstract][Full Text] [Related]
32. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek]. Fiebig H; Kahlert H Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292 [No Abstract] [Full Text] [Related]
33. Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard. Larenas-Linnemann DE; Finegold I; Nelson H Ann Allergy Asthma Immunol; 2012 Jul; 109(1):6-9. PubMed ID: 22727150 [No Abstract] [Full Text] [Related]
36. Quality and clinical efficacy of allergen mixtures. Malling HJ Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):253-7; discussion 257. PubMed ID: 17393747 [No Abstract] [Full Text] [Related]
37. EAACI guidelines on allergen immunotherapy: Executive statement. Muraro A; Roberts G; Halken S; Agache I; Angier E; Fernandez-Rivas M; Gerth van Wijk R; Jutel M; Lau S; Pajno G; Pfaar O; Ryan D; Sturm GJ; van Ree R; Varga EM; Bachert C; Calderon M; Canonica GW; Durham SR; Malling HJ; Wahn U; Sheikh A Allergy; 2018 Apr; 73(4):739-743. PubMed ID: 29380390 [No Abstract] [Full Text] [Related]
38. Are we following practice parameter guidelines on allergen immunotherapy? Chacko T Ann Allergy Asthma Immunol; 2008 Feb; 100(2):178. PubMed ID: 18320926 [No Abstract] [Full Text] [Related]
39. EAACI guidelines on allergen immunotherapy-Out with the old and in with the new. Agache I Allergy; 2018 Apr; 73(4):737-738. PubMed ID: 29319886 [No Abstract] [Full Text] [Related]
40. Allergen stability of testing/treatment boards and immunotherapy vials with various diluents. Nida A; Leatherman B; Plunkett G; Mire B Int Forum Allergy Rhinol; 2015 Nov; 5(11):1028-35. PubMed ID: 26153653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]